Sign in
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Search here...
Search
Subscribe
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Search here...
Search
Dose Daily News Bureau
facebook
instagram
linkedin
Exclusive Content
10th Indian Pharmacopoeia Launched , with Wider Medicine Coverage & Updated Testing Standards
Dose daily
Dose Daily News Bureau
-
January 3, 2026
Regulatory Alert in India: Government Restricts Nimesulide Formulations Above 100 mg
Dose daily
Dose Daily News Bureau
-
January 2, 2026
UAE Drug Regulations – What Travellers Should Know About Tramadol
Dose daily
Dose Daily News Bureau
-
December 29, 2025
Novo Nordisk’s Wegovy Becomes First FDA Approved Weight Loss Drug
Dose daily
Dose Daily News Bureau
-
December 27, 2025
USFDA Flags Compliance Issues at Sun Pharma & Aurobindo Pharma After Inspections
Dose daily
Dose Daily News Bureau
-
December 23, 2025
NMC Issues New Guidelines on Prescription Legibility to Reduce Medication Errors
Dose daily
Dose Daily News Bureau
-
December 21, 2025
1
...
27
28
29
...
41
Page 28 of 41
I want in
I've read and accept the
Privacy Policy
.
FSSAI Bans Use of Metallic Pins and Wires in Food Packaging
Dose Daily News Bureau
-
June 15, 2026
Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats
Breaking News
Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order
Breaking News
FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes
Breaking News
The FDA has outlined its updated strategy for generic drug oversight
Breaking News
Orionis Biosciences Announces $1.44B Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines
Breaking News
×